Brief: Psyence Biomed Announces Export Of Gmp-Manufactured Natural Psilocybin (Npx-5) To Australia For Ongoing Phase Iib Clinical Trial
03/03/2026 14:15
March 3 (Reuters) - Psyence Biomedical Ltd PBM.O: PSYENCE BIOMED ANNOUNCES EXPORT OF GMP-MANUFACTURED NATURAL PSILOCYBIN (NPX-5) TO AUSTRALIA FOR ONGOING PHASE IIB CLINICAL TRIAL Source text: ID:nGNX3JyyKR Further company coverage: PBM.O ((Reuters.Briefs@thomsonreuters.com;))